Physician profile
William E Hughes
NPI 1053366641
$5,579.93
in general payments reported to CMS, 2019-2025
45 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $267 · 2021: $735 · 2022: $488 · 2023: $979 · 2024: $1,339 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,408 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,408.42 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,191.91 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $687.82 | 2019-2024 | Myrbetriq |
| Antares Pharma, INC. | $491.85 | 2019-2025 | Xyosted, Tlando |
| Abbvie INC. | $263.96 | 2022-2025 | |
| Procept Biorobotics Corporation | $236.30 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $225.13 | 2019-2025 | Rezum Generator, Lithovue |
| Endo Pharmaceuticals INC. | $197.35 | 2019-2024 | Xiaflex |
| Janssen Biotech, INC. | $185.17 | 2025 | Erleada |
| Clarus Therapeutics INC. | $153.45 | 2021 | |
| Medtronic, INC. | $140.45 | 2023-2024 | Interstim |
| Pfizer INC. | $134.18 | 2019-2024 | |
| Myovant Sciences INC. | $133.19 | 2021-2022 | |
| Axonics, INC. | $126.87 | 2023-2024 | Axonics, Bulkamid |
| Progenics Pharmaceuticals, INC. | $121.17 | 2021-2025 | Pylarify |
| Endo USA, INC. | $105.64 | 2024 | Xiaflex |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $86.10 | 2020-2024 | |
| Coloplast Corp | $80.84 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $76.56 | 2020-2024 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $72.64 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $66.87 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Halozyme INC | $62.15 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $59.84 | 2022-2023 | Seglentis |
| Allergan, INC. | $58.96 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $57.00 | 2024-2025 | Adstiladrin |
| Tolmar, INC. | $54.16 | 2024-2025 | Eligard, Jatenzo |
| Alnylam Pharmaceuticals INC. | $46.81 | 2021 | |
| 180 Medical, INC. | $43.90 | 2021-2024 | Gentlecath Glide |
| Olympus America INC. | $41.38 | 2019-2025 | Itind System |
| Merck Sharp & Dohme LLC | $39.83 | 2022-2025 | Lynparza |
| Urogen Pharma, INC. | $37.49 | 2021-2023 | Jelmyto |
| Immunitybio, INC. | $34.41 | 2025 | |
| Janssen Scientific Affairs, LLC | $32.24 | 2019 | |
| Teleflex LLC | $31.20 | 2025 | Barrigel |
| Kerecis Limited | $25.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Travere Therapeutics, INC. | $21.83 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $19.96 | 2023 | Trelstar |
| Zyla Life Sciences, INC. | $17.71 | 2020 | |
| Baxter Healthcare | $17.03 | 2022 | |
| Rochester Medical Corporation | $16.53 | 2021 | |
| Foundation Medicine, INC. | $14.89 | 2020 | |
| Lilly USA, LLC | $14.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.05 | 2022 | |
| Novo Nordisk INC | $14.02 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.93 | 2022 | |
| Photocure INC | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.